Asia Pacific Peripheral Intervention Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773336
  • Report
  • Region: Asia, Asia Pacific
  • Allied Analytics LLP
1 of 2
Peripheral intervention procedures are minimal invasive surgeries performed to remove plaques, which is a root cause of several diseases related to peripheral artery. Peripheral intervention surgeries are performed to restore the blood flow of the arteries. They are also used to remove clotting that prevents the flow of oxygenated blood. The increasing aging population and rising prevalence of heart diseases are augmenting the growth of peripheral intervention market in Asia-Pacific region. Moreover, technological innovations, shifting healthcare dynamics and growing clinical experiences are further driving the growth of peripheral intervention market in this region. Increasing number of patients with heart-related problems in India, China and Japan resulting in rising demand for peripheral intervention procedures. Thus, the peripheral intervention market would show remarkable growth during the forecast period.

The Asia-Pacific peripheral intervention market is segmented on the basis of device type, application and geography. Based on devices type, the market is segmented into stents, balloons, PTCA devices and others. Based on application, the Asia-Pacific intervention procedures market is categorized into vascular procedures, oncology procedures, neurology procedures, skin procedures and others (hepatic, renal and uteral). The Asia-Pacific peripheral intervention market is segmented geographically into China, Japan, India, Australia, Singapore, Malaysia and others. Emerging economies such as India, China, Singapore and Malaysia are the potential geographies for market expansion due to improving healthcare standards. These economies have a large presence of domestic manufacturers, which contribute to an increase in the market competition. New product launches, R&D and collaborations are the key strategies adopted by the crucial players of this market. The companies profiled in this market include: Abbott Laboratories, AngioDynamics Inc., C.R. Bard Inc., Boston Scientific Corporation, Medtronic Inc., Cordis Corporation, Terumo Corporation, Braun Melsungen AG and few others.

TAKE A WAY

This report provides an in-depth coverage of the Asia-Pacific peripheral intervention market including drivers, restraints and opportunities that would help professionals to better understand market behavior
The projections in this report are made by analyzing the current market trends that may contribute to the future market potential for the period of 20142020
Detailed study of the strategies of key leaders, partnerships and acquisitions in the Asia-Pacific peripheral intervention market would prove to be informative for professionals in the corporate sector
Porters Five Forces analysis examines the competitive structure of the Asia-Pacific peripheral intervention market and would assist market strategists in making decisions
Pin-point analysis of geographic segments help to identify opportunities for growth within the Asia-Pacific peripheral intervention market
Identification of key investment pockets for Asia-Pacific peripheral intervention market would provide strategic assistance to decision makers
Market attractiveness analysis has been included in this report for various devices used for peripheral intervention and geographic segmentation with detailed analysis of factors responsible for rapid growth of the market segments

PERIPHERAL INTERVENTION MARKET KEY SEGMENTS

The Asia-Pacific peripheral intervention market is segmented into three categories on the basis of device type, application and geography.

BY DEVICES TYPE

Stents

Drug eluting stents
Bio-absorbable stents
Balloon inflation devices
Bare metal stents

Balloons

Normal balloons
Drug eluting balloons
Cutting balloons
Scoring balloons

PTCA devices

Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding c



* This report will be delivered in 12 Business Days. *
READ MORE
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll